NEOVACS
Identification
Listing sponsor / Agent
Invest Securities
Symbol
ALNEV
ISIN code
FR0004032746
Exchange / Market
Euronext Growth
Trading location
Paris
ICB
Biotechnology
Activity description
Neovacs, a spin-off from Pierre & Marie Curie University in Paris, is a biotechnology company focused on an active immunotherapy technology platform, with applications in autoimmune diseases and other chronic conditions. It was founded by Professor Daniel Zagury, MD, PhD, one of the world’s leading immunologists.
Website address
http://www.neovacs.fr
Issuer website
http://www.neovacs.fr
Operation
IPO date
Thu 15/04/2010
IPO type
Initial Public offering
Catégorie
IPO